Catapres side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Catapres. Common side effects include asthma among females, and abdominal pain among males.

The phase IV clinical study is created by eHealthMe based on 6,396 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 01, 2023

6,396 people who take Catapres and have side effects are studied.

What is Catapres?

Catapres has active ingredients of clonidine hydrochloride. It is used in high blood pressure. Currently, eHealthMe is studying from 6,535 Catapres users.

Number of Catapres reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Catapres?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on clonidine hydrochloride (the active ingredients of Catapres) and Catapres (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Catapres:

Catapres (6,535 reports)

Common Catapres side effects:

High blood pressure: 699 reports
Pain: 604 reports
Fatigue (feeling of tiredness): 561 reports
Headache (pain in head): 468 reports
Weakness: 441 reports
Rashes (redness): 397 reports
Drug ineffective: 367 reports

All Catapres side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Modafinil and Horizant drug interaction - 8 seconds ago
Propafenone Hydrochloride and Valsartan drug interaction - 10 seconds ago
Ginseng and Hydroxyzine drug interaction - 14 seconds ago
Anexsia and Simvastatin drug interaction - 30 seconds ago
Latuda and Horizant drug interaction - 30 seconds ago
Sofosbuvir and Cardiac Failure Aggravated - 30 seconds ago
Ciloxan and Urinary Tract Infection - 48 seconds ago
Topiramate and Pramipexole Dihydrochloride drug interaction - 57 seconds ago
Cytarabine and Otitis - a minute ago
Colchicine and Secretion Discharge - a minute ago